K092223

Substantially Equivalent

MODIFICATION TO: BINAXNOW INFLUENZA A & B TEST

Applicant: Binax, Inc.
Product code: PSZ
Advisory panel: Microbiology
Date received: 2009-07-23
Decision date: 2009-08-12
Decision: Substantially Equivalent
Clearance type: Special
Location: Scarborough, ME, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.